UroFiber 60Q offers clear technological advantages. Compared to other fiber lasers, it delivers 20% higher laser peak power and 15% higher average output laser power, significantly enhancing performance, precision, and treatment speed. In laser lithotripsy, its increased power allows for rapid stone fragmentation, reducing treatment time and minimizing collateral damage, leading to faster patient recovery. In soft tissue treatments, the laser’s precision reduces bleeding, minimizes thermal damage, and shortens recovery time, offering a safer, more effective treatment experience for patients.

The FDA clearance of UroFiber 60Q not only validates its safety and effectiveness but also opens up new opportunities for Rhein Laser to expand its reach in the U.S. and global markets. As the first Chinese company to achieve FDA clearance for thulium fiber laser technology, Rhein Laser is poised to bring its innovative solutions to a wider audience and continue driving advancements in medical treatments worldwide.